Lack of association of a single-nucleotide polymorphism of the ?-opioid receptor gene with anxiety-related traits: Results from a cross-sectional study of adults and a longitudinal study of children-Reference-Cited by-同舟云学术

Lack of association of a single-nucleotide polymorphism of the ?-opioid receptor gene with anxiety-related traits: Results from a cross-sectional study of adults and a longitudinal study of children

Published:2002-07-29 Issue:6 Volume:114 Page:659-664
ISSN:0148-7299
Container-title:American Journal of Medical Genetics
language:en
Short-container-title:Am. J. Med. Genet.

Author:

Jorm Anthony F.,Prior Margot,Sanson Ann,Smart Diana,Zhang Yafei,Tan Susan,Easteal Simon

Publisher

Wiley

Subject

Genetics (clinical)

Reference50 articles.

1. Assessment of the Validity of Easy and Difficult Temperament through Observed Mother-Child Behaviours

2. American Psychiatric Association. 1987. Diagnostic and statistical manual for mental disorders, 3rd Ed. Revised. DSM-III-R. Washington DC: APA.

3. The personal disturbance scale (DSSI/sAD): Development, use and structure

4. The personal disturbance scale (DSSI/sAD): structural cross-validation and proposed short forms

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study;BMC Cancer;2021-07-30

Mu-Opioid Receptor Polymorphism Moderates Sensitivity to Parental Behaviors During Characterization of Personality Traits

;Neuropsychiatric Disease and Treatment;2020-09

3. Parental overcontrol x OPRM1 genotype interaction predicts school-aged children’s sympathetic nervous system activation in response to performance challenge;Research in Developmental Disabilities;2018-11

4. Mu opioid receptor polymorphism, early social adversity, and social traits;Social Neuroscience;2015-11-24

5. Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder;Human Psychopharmacology: Clinical and Experimental;2013-05